Archer: An innovative digihealth platform transforming the interoperability of clinical trial data systems, saving healthcare providers money and time
Lead Participant:
IGNITE DATA LIMITED
Abstract
IgniteData is a rapidly growing, digihealth SME with a vision to transform the interoperability of healthcare provider's (Electronic Health Records; EHRs) and clinical trial sponsor's data management (Electronic Data Capture; EDC) solutions.
Clinical trials are pivotal in the development of new and effective medicines (\>103,000 trials globally; ~5% in the UK). Furthermore, much trial-relevant patient data already exists within a healthcare provider's EHR system. Despite this, current EHR-to-EDC solutions are lagging behind industry demand. There are many different EHR and EDC systems used by healthcare providers and trial sponsors, each with their own data structures. Therefore, each new clinical trial demands significant work to map EHR data structures to the relevant EDC.
The siloed and disparate nature of the EHR-to-EDC landscape causes significant costs, delays (87,000hrs/Phase-III trial), and stress for the people involved. Currently, "around 20% of the total costs of a study (~£13-19m) is allocated to duplicating and verifying data" \[AppliedClinicalTrials,2021\].
Into this space IgniteData is developing an innovative digital-health Software-as-a-Service (SaaS) product, 'Archer'. Archer provides a 'one-stop-shop' for EHR and EDC operability, delivering seamless interoperability between multiple EHR and EDC systems on one platform. A pilot study with academia/pharma demonstrated saving of 67hrs/patient over 20 patient visits (97% improvement), with estimated savings of £11.7k/patient(£4.7m for 400 patients).
Clinical trials are pivotal in the development of new and effective medicines (\>103,000 trials globally; ~5% in the UK). Furthermore, much trial-relevant patient data already exists within a healthcare provider's EHR system. Despite this, current EHR-to-EDC solutions are lagging behind industry demand. There are many different EHR and EDC systems used by healthcare providers and trial sponsors, each with their own data structures. Therefore, each new clinical trial demands significant work to map EHR data structures to the relevant EDC.
The siloed and disparate nature of the EHR-to-EDC landscape causes significant costs, delays (87,000hrs/Phase-III trial), and stress for the people involved. Currently, "around 20% of the total costs of a study (~£13-19m) is allocated to duplicating and verifying data" \[AppliedClinicalTrials,2021\].
Into this space IgniteData is developing an innovative digital-health Software-as-a-Service (SaaS) product, 'Archer'. Archer provides a 'one-stop-shop' for EHR and EDC operability, delivering seamless interoperability between multiple EHR and EDC systems on one platform. A pilot study with academia/pharma demonstrated saving of 67hrs/patient over 20 patient visits (97% improvement), with estimated savings of £11.7k/patient(£4.7m for 400 patients).
Lead Participant | Project Cost | Grant Offer |
---|---|---|
  | ||
Participant |
||
IGNITE DATA LIMITED |
People |
ORCID iD |
Richard Yeatman (Project Manager) |